M. Bakir

Managing Ischemic Heart Disease in Women: Role of a Women’s Heart Center

A. Volgman, Abha Khandelwal, Melissa J. Tracy, 2021, Current Atherosclerosis Reports.

N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women’s Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD) study

C. Pepine, G. Sopko, E. Handberg, 2020, PloS one.

Not typical angina and mortality in women with obstructive coronary artery disease: Results from the Women’s Ischemic Syndrome Evaluation study (WISE)

S. Reis, L. Shaw, S. Kelsey, 2020, International journal of cardiology. Heart & vasculature.

Heart failure hospitalization in women with signs and symptoms of ischemia: A report from the women's ischemia syndrome evaluation study.

C. Pepine, G. Sopko, B. Sharif, 2016, International journal of cardiology.

Prescribing statins to patients with nonalcoholic fatty liver disease: real cardiovascular benefits outweigh theoretical hepatotoxic risk.

M. Al Bakir, J. O'donohue, M. Crook, 2009, Cardiovascular therapeutics.

Cardiac magnetic resonance imaging for myocardial perfusion and diastolic function-reference control values for women.

P. Slomka, Debiao Li, B. Sharif, 2016, Cardiovascular diagnosis and therapy.